1 Department of Diabetes and Endocrinology;
2 Department of Clinical Chemistry;
3 Department of Radiology, New Cross Hospital, Wolverhampton WV10 0QP, UK;
4 Department of Clinical Biochemistry, University Hospital Birmingham, Birmingham B29 6JB, UK;
5 Research Institute, Wolverhampton University, West Midlands WY1 1SB, UK
Corresponding author: Prof R Gama, Department of Clinical Chemistry, New Cross Hospital, Wolverhampton WV10 0QP, UK. Email: rousseau.gama{at}rwh-tr.nhs.uk
Antibody interference in immunoassays is an underestimated problem, which has the potential to cause patient harm and waste health-care resources. We report a case where thyroglobulin antibodies generated a false-positive thyroglobulin result delaying the diagnosis of thyrotoxicosis factitia masquerading as recurrent Graves' disease. A high index of clinical suspicion and good laboratory-clinician communication underpins effective clinical and laboratory strategies to detect potentially erroneous laboratory results due to endogenous antibody interference in immunoassays.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. C Heijboer, R. G Ijzerman, A. A Bouman, and M. A Blankenstein Two cases of antiruthenium antibody interference in Modular free thyroxine assay Ann Clin Biochem, May 1, 2009; 46(3): 263 - 264. [Full Text] [PDF] |
||||